The circadian mutation PER2 S662G is linked to cell cycle progression and tumorigenesis

Cell Death and Differentiation

Volumn 19, Issue 3, 2012, Pages 397-405

  Gu, X ^a   Xing, L ^a   Shi, G ^a   Liu, Z ^a   Wang, X ^a   Qu, Z ^a   Wu, X ^a   Dong, Z ^a   Gao, X ^a   Liu, G ^a   Yang, L ^b   Xu, Y ^a  

^a NANJING UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

cell cycle; circadian rhythms; FASPS; PER2; tumorigenesis

Indexed keywords

E1A PROTEIN; PER2 PROTEIN; RAS PROTEIN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIVISION; CELL GROWTH; CIRCADIAN RHYTHM; CONTROLLED STUDY; CYCLIN D1 GENE; EMBRYO; FAMILIAL ADVANCED SLEEP PHASE SYNDROME; GENE; GENE EXPRESSION PROFILING; GENE MUTATION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE C MYC; OSCILLATION; P21 GENE; P27 GENE; PER2 GENE; PRIORITY JOURNAL; SLEEP AROUSAL DISORDER; SLEEP DISORDER; WAKEFULNESS; X RAY;

AMINO ACID SUBSTITUTION; ANIMALS; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CIRCADIAN RHYTHM; FIBROBLASTS; MICE; MICE, MUTANT STRAINS; MUTATION, MISSENSE; NEOPLASM PROTEINS; PERIOD CIRCADIAN PROTEINS; SLEEP DISORDERS, CIRCADIAN RHYTHM;

MAMMALIA; MUS;

EID: 84857057191     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2011.103     Document Type: Article

References (35)

1. Lowrey PL, Takahashi JS. Mammalian circadian biology: Elucidating genome-wide levels of temporal organization. Annu Rev Genomics Hum Genet 2004; 5: 407-441. (Pubitemid 39362752)
2. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002; 418: 935-941. (Pubitemid 34976023)
3. Young MW, Kay SA. Time zones: A comparative genetics of circadian clocks. Nat Rev Genet 2001; 2: 702-715. (Pubitemid 33674792)
4. Panda S, Antoch MP, Miller BH, Su AI, Schook AB, Straume M et al. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 2002; 109: 307-320. (Pubitemid 34606874)
5. Schmutz I, Ripperger JA, Baeriswyl-Aebischer S, Albrecht U. The mammalian clock component PERIOD2 coordinates circadian output by interaction with nuclear receptors. Genes Dev 2010; 24: 345-357.
6. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002; 111: 41-50.
7. Yang X. A wheel of time: The circadian clock, nuclear receptors, and physiology. Genes Dev 2010; 24: 741-747.
8. Gery S, Komatsu N, Baldjyan L, Yu A, Koo D, Koeffler HP. The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 2006; 22: 375-382.
9. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2001; 93: 1557-1562. (Pubitemid 32998485)
10. Baan R, Grosse Y, Straif K, Secretan B, El Ghissassi F, Bouvard V et al. A review of human carcinogens-Part F: Chemical agents and related occupations. Lancet Oncol 2009; 10: 1143-1144.
11. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V et al. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 2007; 8: 1065-1066.
12. Jones CR, Campbell SS, Zone SE, Cooper F, DeSano A, Murphy PJ et al. Familial advanced sleep-phase syndrome: A short-period circadian rhythm variant in humans. Nat Med 1999; 5: 1062-1065. (Pubitemid 29439580)
13. Toh KL, Jones CR, He Y, Eide EJ, Hinz WA, Virshup DM et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science (New York, NY) 2001; 291: 1040-1043. (Pubitemid 32157412)
14. Xu Y, Padiath QS, Shapiro RE, Jones CR, Wu SC, Saigoh N et al. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 2005; 434: 640-644. (Pubitemid 40488555)
15. Xu Y, Toh KL, Jones CR, Shin JY, Fu YH, Ptacek LJ. Modeling of a human circadian mutation yields insights into clock regulation by PER2. Cell 2007; 128: 59-70. (Pubitemid 46048889)
16. Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, Parant JM et al. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 2004; 119: 861-872. (Pubitemid 40017691)
17. Bae K, Jin X, Maywood ES, Hastings MH, Reppert SM, Weaver DR. Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock. Neuron 2001; 30: 525-536. (Pubitemid 32530594)
18. Baylies MK, Bargiello TA, Jackson FR, Young MW. Changes in abundance or structure of the per gene product can alter periodicity of the Drosophila clock. Nature 1987; 326: 390-392. (Pubitemid 17053766)
19. Yang Z, Sehgal A. Role of molecular oscillations in generating behavioral rhythms in Drosophila. Neuron 2001; 29: 453-467. (Pubitemid 32206483)
20. Cook JL, May DL, Wilson BA, Walker TA. Differential induction of cytolytic susceptibility by E1A, myc, and ras oncogenes in immortalized cells. J Virol 1989; 63: 3408-3415. (Pubitemid 19181401)
21. Sherr CJ. Principles of tumor suppression. Cell 2004; 116: 235-246. (Pubitemid 38167315)
22. Ozturk N, Lee JH, Gaddameedhi S, Sancar A. Loss of cryptochrome reduces cancer risk in p53 mutant mice. Proc Natl Acad Sci USA 2009; 106: 2841-2846.
23. Embree-Ku M, Boekelheide K. Absence of p53 and FasL has sexually dimorphic effects on both development and reproduction. Exp Biol Med (Maywood) 2002; 227: 545-553.
24. Grechez-Cassiau A, Rayet B, Guillaumond F, Teboul M, Delaunay F. The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation. J Biol Chem 2008; 283: 4535-4542.
25. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816. (Pubitemid 23346377)
26. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD et al. The consensus coding sequences of human breast and colorectal cancers. Science (New York, NY) 2006; 314: 268-274. (Pubitemid 44571966)
27. Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL. Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. Neoplasia 2007; 9: 797-800. (Pubitemid 47623419)
28. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, Chang JG. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 2005; 26: 1241-1246.
29. Gauger MA, Sancar A. Cryptochrome, circadian cycle, cell cycle checkpoints, and cancer. Cancer Res 2005; 65: 6828-6834. (Pubitemid 41060721)
30. Miller BH, McDearmon EL, Panda S, Hayes KR, Zhang J, Andrews JL et al. Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc Natl Acad Sci US A 2007; 104: 3342-3347. (Pubitemid 46364161)
31. Yang Q, Pando BF, Dong G, Golden SS, van Oudenaarden A. Circadian gating of the cell cycle revealed in single cyanobacterial cells. Science (New York, NY) 2010; 327: 1522-1526.
32. Lu Y, Cross FR. Periodic cyclin-Cdk activity entrains an autonomous Cdc14 release oscillator. Cell 2010; 141: 268-279.
33. King DP, Zhao Y, Sangoram AM, Wilsbacher LD, Tanaka M, Antoch MP et al. Positional cloning of the mouse circadian clock gene. Cell 1997; 89: 641-653. (Pubitemid 27511774)
34. Wang X, Tang J, Xing L, Shi G, Ruan H, Gu X et al. Interaction of MAGED1 with nuclear receptors affects circadian clock function. Embo J 2010; 29: 1389-1400.
35. Morita S, Kojima T, Kitamura T. Plat-E: An efficient and stable system for transient packaging of retroviruses. Gene Ther 2000; 7: 1063-1066. (Pubitemid 30398356)